<table sstyle="width:80%" align="center" border=1>
<tr>
<th>mv</th>
<th>dw</th>
<th>HMMCrowd</th>
</tr>
<tr>
<td width=33%>
[35, 41] ondansetron, droperidol, perphenazine,<br>[42, 43] metoclopramide<br>[80, 81] ondansetron<br>[84, 85] droperidol<br>[88, 89] perphenazine<br>[92, 93] metoclopramide<br>[97, 98] placebo<br></td>
<td width=33%>
[4, 12] ondansetron, droperidol, perphenazine, and metoclopramide<br>[30, 35] intravenous (i.v.)<br>[35, 43] ondansetron, droperidol, perphenazine, and metoclopramide<br>[80, 81] ondansetron<br>[84, 85] droperidol<br>[88, 89] perphenazine<br>[92, 93] metoclopramide<br>[96, 98] or placebo<br>[109, 110] metoclopramide<br></td>
<td width=33%>
[3, 12] prophylactic ondansetron, droperidol, perphenazine, and metoclopramide<br>[30, 35] intravenous (i.v.)<br>[35, 43] ondansetron, droperidol, perphenazine, and metoclopramide<br>[64, 70] abdominal hysterectomy (TAH).<br>[80, 98] ondansetron 4 mg, droperidol 1.25 mg, perphenazine 5 mg, metoclopramide 10 mg, or placebo<br>[102, 104] anesthesia.<br>[109, 110] metoclopramide<br>[119, 120] ondansetron<br>[127, 129] anesthesia.<br>[136, 137] droperidol<br>[183, 184] ondansetron<br>[189, 190] droperidol<br>[196, 197] perphenazine<br>[208, 209] placebo<br>[218, 219] Metoclopramide<br>[223, 229] ondansetron, droperidol, and perphenazine<br>[239, 240] perphenazine<br>[251, 252] perphenazine<br>[260, 261] TAH.<br></td>
</tr>
